Carcereri de Prati Alessandra, Butturini Elena, Rigo Antonella, Oppici Elisa, Rossin Michele, Boriero Diana, Mariotto Sofia
Department of Neuroscience, Biomedicine and Movement Sciences, Section of Biological Chemistry, University of Verona, Strada le Grazie 8, Verona, 37134, Italy.
Department of Medicine, Section of Hematology, Cancer Research and Cell Biology Laboratory University of Verona, Piazzale Scuro, Verona, 37134, Italy.
J Cell Biochem. 2017 Oct;118(10):3237-3248. doi: 10.1002/jcb.25972. Epub 2017 May 3.
Tumor dormancy is a poorly understood stage in cancer progression characterized by mitotic cycle arrest in G0/G1 phase and low metabolism. The cells survive in a quiescent state and wait for appropriate environmental conditions to begin proliferation again giving rise to metastasis. Despite their key role in cancer development and metastasis, the knowledge about their biology and origin is still very limited due to the poorness of established in vitro models that faithfully recapitulated tumor dormancy. Using at least three cycles of 1% O hypoxia and reoxygenation, we establish and characterize the hypoxia-resistant human breast cancer cell line chMDA-MB-231 that can stably survive under 1% O condition by entering into dormant state characterized by arrest in G0/G1 phase and low metabolism. This dormant state is reversible since once replaced in normoxia the cells recover the proliferation rate in 2 weeks. We show that chronic hypoxia induces autophagy that may be the survival mechanism of chMDA-MB-231 cells. Furthermore, the data in this work demonstrate that cycling hypoxic/reoxygenation stress selects MDA-MB-231 population that presents the cancer stem-like phenotype characterized by CD24 /CD44 /ESA expression and spheroid forming capacity. We believe that our study presents a promising approach to select dormant breast cancer cells with stem-like phenotype using the hypoxia/reoxygenation regimen that may represent an area with profound implications for therapeutic developments in oncology. J. Cell. Biochem. 118: 3237-3248, 2017. © 2017 Wiley Periodicals, Inc.
肿瘤休眠是癌症进展过程中一个尚未被充分理解的阶段,其特征是细胞有丝分裂周期停滞在G0/G1期且代谢水平较低。细胞以静止状态存活,等待合适的环境条件再次开始增殖,进而引发转移。尽管它们在癌症发展和转移中起关键作用,但由于缺乏能忠实地模拟肿瘤休眠的成熟体外模型,关于它们的生物学特性和起源的知识仍然非常有限。通过使用至少三个周期的1%氧气低氧和复氧处理,我们建立并鉴定了耐低氧的人乳腺癌细胞系chMDA-MB-231,该细胞系在1%氧气条件下可通过进入以G0/G1期停滞和低代谢为特征的休眠状态而稳定存活。这种休眠状态是可逆的,因为一旦置于常氧环境中,细胞在两周内就能恢复增殖速率。我们发现慢性低氧诱导自噬,这可能是chMDA-MB-231细胞的存活机制。此外,本研究的数据表明,循环低氧/复氧应激选择出了具有癌症干细胞样表型的MDA-MB-231细胞群体,其特征为CD24-/CD44+/ESA表达和球体形成能力。我们相信,我们的研究提出了一种有前景的方法,即使用低氧/复氧方案来选择具有干细胞样表型的休眠乳腺癌细胞,这可能代表了一个对肿瘤学治疗发展具有深远意义的领域。《细胞生物化学杂志》118: 3237 - 3248, 2017。© 2017威利期刊公司